Search

everythinglearnresearchcommunity

for

Search:↓

Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Microbes might play a role in vitiligo.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

Maintaining anticoagulation is crucial for patients with antiphospholipid syndrome.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Vitiligo affects overall health and self-esteem, needing more research and awareness.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

The summit concluded that new treatments like Jak inhibitors show promise for Alopecia Areata and personalized approaches are needed.

Coconut seed extract may effectively treat scabies in rabbits by killing mites and reducing inflammation.

People with Alopecia Areata are more likely to have prediabetes and obesity.

Testosterone can both promote hair growth and cause baldness by affecting hair growth signals.

Testosterone may worsen hair loss by affecting hair growth signals, while different prostaglandins can either hinder or promote hair growth.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Oxidative stress is linked to mild patchy alopecia areata.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Protein analysis shows aging changes in scalp cell types from women.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Combining light therapy, acid, and microneedling improves hair regrowth in stubborn hair loss cases.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

A woman with severe hair loss was successfully treated with the drug adalimumab.